Which statement about the FDA 510(k) clearance pathway is accurate?

Which statement about the FDA 510(k) clearance pathway is accurate?

• A. It requires demonstration of substantial equivalence to a predicate device
• B. It guarantees marketing approval regardless of safety data
• C. It is issued only if the device existed before 1976
• D. It does not require any premarket submission

Answer: (A)

The main idea here is that the 510(k) pathway hinges on substantial equivalence to a predicate device. When a company submits a 510(k), it must show that the new device has the same intended use and similar technological characteristics as a legally marketed device already on the market, and that any differences don’t raise new safety or effectiveness questions. If FDA determines the device is substantially equivalent, it is cleared for marketing. This isn’t a guarantee of approval in the PMA sense, and it isn’t a free pass—FDA still reviews to ensure the device is at least as safe and effective as the predicate. It also isn’t limited to devices that existed before 1976; many post-1976 devices use the 510(k) route if they can demonstrate substantial equivalence to a predicate. And yes, a 510(k) submission is indeed required before marketing; there is a premarket submission involved, not none at all.

The main idea here is that the 510(k) pathway hinges on substantial equivalence to a predicate device. When a company submits a 510(k), it must show that the new device has the same intended use and similar technological characteristics as a legally marketed device already on the market, and that any differences don’t raise new safety or effectiveness questions. If FDA determines the device is substantially equivalent, it is cleared for marketing.

This isn’t a guarantee of approval in the PMA sense, and it isn’t a free pass—FDA still reviews to ensure the device is at least as safe and effective as the predicate. It also isn’t limited to devices that existed before 1976; many post-1976 devices use the 510(k) route if they can demonstrate substantial equivalence to a predicate. And yes, a 510(k) submission is indeed required before marketing; there is a premarket submission involved, not none at all.